This inventor holds 1 USPTO granted patent. Top assignee: Protera S.r.l.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations by Alessandro Mordini in Hematological Treatments
Introduction
Alessandro Mordini is a notable inventor based in Florence, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hematological tumors and retroviral infections. His innovative work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Mordini holds a patent for "Prodrugs activated by RNA-dependent DNA-polymerases." This invention provides prodrugs that are activated by RNA-dependent DNA-polymerases, offering methods for treating hematological tumors and blood derivatives from patients affected by retroviral infections. The patent also outlines methods for preparing pharmaceutical compositions containing these prodrugs. He has 1 patent to his name.
Career Highlights
Alessandro Mordini is associated with Protera S.r.l., a company focused on innovative pharmaceutical solutions. His work at Protera has allowed him to explore and develop groundbreaking treatments that address critical health issues.
Collaborations
Mordini has collaborated with notable colleagues, including Alessandro Quattrone and Ivano Bertini. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Alessandro Mordini's contributions to the field of pharmaceuticals, particularly through his patent on prodrugs activated by RNA-dependent DNA-polymerases, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating hematological conditions and retroviral infections.